Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017
- Trzcionkowska, K.
- Vehmeijer, W.
- Kerkhoff, F.T.
- Bauer, N.J.C.
- Bennebroek, C.A.M.
- Dijk, P.H.
- Dijkman, K.P.
- Dungen, F.A.M. van den
- Eggink, C.A.
- Feenstra, R.P.G.
- Groenendaal, F.
- Heijst, A.F. van
- Hoeven, M. van der
- Kornelisse, R.F.
- Kraal-Biezen, E.
- Lopriore, E.
- Onland, W.
- Lavalette, V.W. Renardel de
- Rijn, Laurentius R. van
- Schuerman, F.
- Simonsz, H.J.
- Voskuil-Kerkhof, E.S.M.
- Witlox, R.
- Termote, J.U.
- Schalij-Delfos, N.E.
DOIAbstract
Contains fulltext : 235444.pdf (Publisher’s version ) (Open Access)PURPOSE: Compare patients treated for Retinopathy of Prematurity (ROP) in two consecutive periods. METHODS: Retrospective inventory of anonymized neonatal and ophthalmological data of all patients treated for ROP from 2010 to 2017 in the Netherlands, subdivided in period (P)1: 1-1-2010 to 31-3-2013 and P2: 1-4-2013 to 31-12-2016. Treatment characteristics, adherence to early treatment for ROP (ETROP) criteria, outcome of treatment and changes in neonatal parameters and policy of care were compared. RESULTS: Overall 196 infants were included, 57 infants (113 eyes) in P1 and 139 (275 eyes) in P2, indicating a 2.1-fold increase in ROP treatment. No differences...
Add to ORKG